TREO VENTURES, LLC

Thesis

Treo Ventures is a venture capital firm established in 2018, with a debut fund of $128 million. They focus on investing in medical technology and digital health innovations that address significant unmet clinical needs, operating globally with a presence in the United States and Ireland. Their investment strategy centers on high-growth companies tackling substantial clinical problems, investing in both early-stage (pre-seed, seed, Series A, Series B) and later-stage companies with demonstrated feasibility and clinical data. Key therapeutic interests include cardiovascular disease, neuro-mediated disorders, orthopedic and spinal diseases, metabolic disorders, oncology, and ophthalmic conditions. Treo Ventures also invests in companies originating from NuXcel, their medical device accelerator. They primarily invest in Series A rounds in US-based startups but consider other stages and geographies. The firm operates as a Registered Investment Adviser.

Related lists

• Pre-seed Healthcare investors
• Seed-stage Healthcare investors
• Series A Healthcare investors